Monday, September 01, 2014
2009 Index Minimize

Report
Number

Description

Category

Date
Issued

47


Rx-360 Summary of the U.S. FDA Guidance on Residual Solvents

Guidance

29-Dec-09

36


Rx-360 Summary of the U.S. FDA’s Guidance on Melamine Contamination

Guidance

09-Aug-09

35


Rx-360 Summary of the U.S. FDA Issues Pharmaceutical Industry Guidance on Preventing Melamine Contamination

Guidance

06-Aug-09

30


Rx-360 Summary of US FDA's Draft Guidance for Industry on PCIDs

Guidance

21-Jul-09

28


Rx-360 Summary of the U.S. FDA Issues Draft Guidance for Industry on Drug Anti-counterfeiting

Regulation

14-Jul-09

22


Rx-360 Summary of the U.S. Congressman Dingell's New US Draft Legislation HR 759

Legislative

16-Jun-09

18


Rx-360 Summary of the new US Congress Draft Legislation on Supply Chain Security

Legislative

01-Jun-09

7


Rx-360 Summary of the U.S. draft US Senate Drug Device Accountability Act of 2009 – Rx-360 Analysis

Legislative

05-May-09

3


Rx-360 Summary of the U.S. Announcement of US Drug and Device Accountability Act of 2008

Legislative

30-Apr-09

 

  

 

2009 © Rx-360